EVALUATION OF DRUG TREATMENT OPTIONS FOR ALZHEIMER'S DISEASE - A REVIEW OF EARLIER STUDIES
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 4
Abstract
Therapeutic treatments for Alzheimer's disease include the cholinesterase inhibitors donepezil, galantamine and rivastigmine. A review of the evidence by searching MEDLINE, Embase, The Cochrane Library and the International Pharmaceutical Abstracts from 1980 through 2007 (July) for placebo-controlled and comparative trials assessing cognition, function, behavior, global change and safety was made. Thirty-three articles on 26 studies were included in the review. Meta-analyses of placebo-controlled data support the drugs modest overall benefits for stabilizing or slowing decline in cognition, function, behavior and clinical global change. Three open-label trials and one double-blind randomized trial directly compared donepezil with galantamine and rivastigmine. Results are conflicting: two studies suggest no differences in efficacy between compared drugs, while one study found donepezil to be more efficacious than galantamine and one study found rivastigmine to be more efficacious than donepezil. Adjusted indirect comparison of placebo-controlled data did not find statistically significant differences among drugs with regard to cognition, but found the relative risk of global response to be better with donepezil and rivastigmine compared with galantamine. Indirect comparisons also favored donepezil over galantamine with regard to behavior, Across trials, the incidence of adverse events was generally lowest for donepezil and highest for rivastigmine. These studies are discussed in this presentation.
Authors and Affiliations
Prof. K. Sri Gouri
Keywords
Related Articles
- EP ID EP618045
- DOI -
- Views 141
- Downloads 0
A REVIEW ARTICLE ON SIGNIFICANCE OF SAMSARJANA KRAMÃ AS PÃSCHÃT KARMÃ
Panchākarma is the highly preferred therapeutic modality to cure any disease with least possibility of recurrence. Panchā karma is always performed in three phases – Pūrva karma (preparatory procedures), Pradhāna karma (...
ANALYSIS OF PREVALENT PATHOLOGIES, PHARMACOLOGICAL TREATMENTS AND THEIR POTENTIAL PROBLEMS IN ELDERLY PATIENTS IN A HOSPITAL OF MENDOZA, ARGENTINA
The goal was to conduct a preliminary assessment of drug use in elderly patients at a Mendoza hospital. An observational, descriptive, transversal of indication-prescription study was carried out during four months. Data...
THE IMPLICATIONS OF FIXED DOSE COMBINATION (FDC) COMPARED TO SINGLE PILL COMBINATIONS (SPC): BASED ON PATIENTS’ VIEW
Fixed dose Combination (FDC) was mainly presented to simplify complex medical regimens and potentially improve adherence. Therefore, it was advocated in several chronic diseases guidelines in hospitals and health authori...
PHARMACOKINETICS SURVEILLANCE ON DRUGS- A REVIEW
All drugs can have negative effects. When they reach the market, there are reasonably safe, yet remain in surveillance by pharmacovigilance. Pharmacokinetics plays a very important role in this because we can have monito...
POLYMORPHISM IN PHARMACEUTICALS
Polymorphism is the phenomenon in which a drug substance can exist in either two or more than two crystalline forms with different physicochemical properties. Obiquity and importance of Polymorphism occurring in pharmace...